ATE452645T1 - Phytoprogestogenen extrakten aus rhizoma ligusticum chuanxiong und ihre verwendungszwecke - Google Patents

Phytoprogestogenen extrakten aus rhizoma ligusticum chuanxiong und ihre verwendungszwecke

Info

Publication number
ATE452645T1
ATE452645T1 AT03792934T AT03792934T ATE452645T1 AT E452645 T1 ATE452645 T1 AT E452645T1 AT 03792934 T AT03792934 T AT 03792934T AT 03792934 T AT03792934 T AT 03792934T AT E452645 T1 ATE452645 T1 AT E452645T1
Authority
AT
Austria
Prior art keywords
phytoprogestogenic
extracts
ligusticum chuanxiong
rhizoma
rhizoma ligusticum
Prior art date
Application number
AT03792934T
Other languages
English (en)
Inventor
Eu Yong
Lis Sa Lim
Mark Butler
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Application granted granted Critical
Publication of ATE452645T1 publication Critical patent/ATE452645T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
AT03792934T 2002-08-20 2003-08-20 Phytoprogestogenen extrakten aus rhizoma ligusticum chuanxiong und ihre verwendungszwecke ATE452645T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40439702P 2002-08-20 2002-08-20
PCT/SG2003/000195 WO2004017983A1 (en) 2002-08-20 2003-08-20 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof

Publications (1)

Publication Number Publication Date
ATE452645T1 true ATE452645T1 (de) 2010-01-15

Family

ID=31946719

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03792934T ATE452645T1 (de) 2002-08-20 2003-08-20 Phytoprogestogenen extrakten aus rhizoma ligusticum chuanxiong und ihre verwendungszwecke

Country Status (6)

Country Link
US (1) US20060068045A1 (de)
EP (1) EP1539205B1 (de)
AT (1) ATE452645T1 (de)
AU (1) AU2003256238A1 (de)
DE (1) DE60330679D1 (de)
WO (1) WO2004017983A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0520587A2 (pt) * 2005-09-30 2009-05-19 Fei Chen uso de derivados de ftalida e composição farmacêutica contendo os mesmos
WO2009097512A1 (en) * 2008-02-01 2009-08-06 Innovative Drug Discovery Inc. Herbal pharmaceutical compositions to treat inflammation and inflammation associated conditions and diseases
CN101677989B (zh) * 2008-02-14 2012-10-10 清华大学 一种防治缺血性脑卒中的药物组合物及其制备方法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN104306372B (zh) * 2014-11-10 2018-05-08 石药集团恩必普药业有限公司 一种丁苯酞制剂组合物及其制备方法与用途
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
JP2019513709A (ja) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． ステロイドホルモン薬学的組成物
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CN106798756A (zh) * 2017-03-03 2017-06-06 四川德成动物保健品有限公司 用于益母生化合剂中川芎有效成分的提取工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708949A (en) * 1985-09-24 1987-11-24 Yaguang Liu Therapeutic composition from plant extracts
CN1123165A (zh) * 1994-11-17 1996-05-29 胡红拴 妇科胎安中药冲剂及制备方法
CN1098099C (zh) * 1999-11-26 2003-01-08 化学工业部西南化工研究设计院 超临界二氧化碳萃取川芎药用有效成分的方法
CN1193776C (zh) * 2000-12-28 2005-03-23 白民刚 一种治疗充血性心力衰竭药剂及其制备方法

Also Published As

Publication number Publication date
EP1539205A4 (de) 2007-07-11
EP1539205B1 (de) 2009-12-23
DE60330679D1 (de) 2010-02-04
US20060068045A1 (en) 2006-03-30
AU2003256238A1 (en) 2004-03-11
EP1539205A1 (de) 2005-06-15
WO2004017983A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
ATE452645T1 (de) Phytoprogestogenen extrakten aus rhizoma ligusticum chuanxiong und ihre verwendungszwecke
EP1706125A4 (de) Verfahren zur behandlung von intraepithelialer prostataneoplasie mit pflanzlichen zusammensetzungen
DE60227068D1 (de) Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen
MY140191A (en) Composition for heart disease, method to prepare same and uses thereof
PL2719384T3 (pl) Nowe 1-naftylo-3-azabicyklo[3.1.0]heksany: wytwarzanie i zastosowanie do leczenia zaburzeń neuropsychiatrycznych
LT2006027A (lt) Farmacinė kompozicija skirta gydyti širdies kraujagyslių ir smegenų kraujagyslių ir susirgimus
WO2002060379A3 (en) Composition comprising extracts of flos lonicerae, fructus forsythiae and radix scutellariae, uses and preparation thereof
NO20044877L (no) Formuleringer anvendelige til behandling av impotens hos kvinner og menn
AR022888A1 (es) Mezcla defoliante, su uso para provocar la caida de las hojas de las plantas y procedimiento para provocar la caida de las hojas de las plantas
ATE327763T1 (de) Pflanzenextrakte und deren anwendung
WO2005049058A8 (fr) Radix salviae miltiorrhizae, extrait et composition destines au traitement des maladies de resistance a l'aspirine
AU2003289535A1 (en) Anti-obesity ingretients from medicinal plants and their composittion
ATE359083T1 (de) Zwiebelextrakte
Slaughter Motivations of long term volunteers at events
CL2004001317A1 (es) Composicion farmaceutica que comprende el antagonista de receptores de progesterona 11b-(4-acetilfenil)-17b-hidroxi-17 alfa-(1,1,2,2,2-pentafluoroetil)-estra-4,9-dien-3-ona y un antiestrogeno puro; y su uso para tratar una enfermedad dependiente de h
ZA200800402B (en) Method for extracting plants of the genus pelargonium, extract produced according to said method, and use thereof
Hazrat et al. Role of economic plants in the community development of Dir valley Khyber Pakhtunkhwa, Pakistan
Nadjafi et al. Ethnopharmacology of Nepeta binaludensis Jamzad a highly threatened medicinal plant of Iran
Park A Study on the ${\ulcorner} $ DongMuSunSaSaSangYakSungSangHumGoGa ${\lrcorner} $'s Origin and Meaning
DE60032931D1 (de) Polypeptide aus den zellkernrezeptor des vitamins d, und ihre verwendung insbesondere zum screening von vitamin d-analoga
Todorovic et al. Regional population dynamics and migration emigrant population of Eastern Serbia: demographic and economic consequences
Mutangadura AIDS and African smallholder agriculture
Hyung et al. Screening of cytotoxicity and antimicrobial effects of hexane extracts from Cornis fructus
PARKING CONTINUED STAFF DEVELOPMENT
AR047501A1 (es) Tratamiento de resistencia a la aspirina con radix salviae miltiorrhizae su extracto y composicion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties